DA
CRBP icon

Doliver Advisors’s Corbus Pharmaceuticals CRBP Stock Holding History

Doliver Advisors’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$518K Buy
+75,975
New +$701K 0.11% 114

Other funds holding CRBP

VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return

Doliver Advisors's CRBP Position: Q3 2026 in Review

Doliver Advisors opened a new position in Corbus Pharmaceuticals (CRBP) in Q3 2026: 75,975 shares worth $518K. The stake represents 0.11% of the portfolio and ranks #114 among its holdings.

6 funds tracked by Wall St. Rank hold CRBP as of Q3 2026.

  • Doliver Advisors held 75,975 shares of Corbus Pharmaceuticals worth $518K as of Q3 2026.
  • Corbus Pharmaceuticals was a new Doliver Advisors position in Q3 2026.
  • Corbus Pharmaceuticals made up 0.11% of Doliver Advisors's portfolio in Q3 2026, its #114 holding.
  • 6 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q3 2026.

Based on Doliver Advisors's 13F filing for Q3 2026, filed 1 Oct 2026.